Easton Pharmaceuticals, Inc. (EAPH)

[wjb007]

EAPH E-Liquids/Cannabis; EAPH and iBliss Inc. executed an agreement for the 100% acquisition of iBliss by EAPH. Subsequent to the June 30th quarter, EAPH issued 218,000,000 shares to iBliss and its subscribers, which are to be held in escrow to be conditionally released as per milestone revenues as stated in its agreement. The agreement has been amended to restructure minor provisions of the agreement that did not require any cash payments which would then result in the release of the shares from escrow, at which time, EAPH will consolidate iBliss revenues into its own financial statements. EAPH owned iBLISS revenues have not been reflected in the financial statements as the terms of the agreement call for revenues to be paid to the subscribers until the cash component of the transaction is earned by the iBliss subscribers.